Type 2 diabetes

There are 11,164 papers on type 2 diabetes in aging research: 1,567 trials and 5,777 observational studies in people, 449 in animals, 43 in cells, 2,838 reviews. The newest story, Nov 22, 2026: “Genetic links to height differ as children grow”.

Disease

11,164 papers study it2,959 more mention it3,711 findings

MeSH

1,195 new papers in 30 daysSee all 14,124 papers on type 2 diabetes

“The highest risk reduction for T2D when compared with control was obtained with dual incretin-based therapy”
Evidence-based ranking of diabetes prevention in prediabetes: A comprehensive network meta-analysis of 378 randomised controlled trialsClinical and translational medicine2026doi:10.1002/ctm2.70829
  • Human trial1,567
  • Humans5,777
  • Animals433
  • Model organisms16
  • Cells43
  • In silico287

Interventions

26

Mediterranean diet

downin humans2

2 studies
  1. Mediterranean diet protects against type 2 diabetes in humans.

    Review

  2. Mediterranean diet protects against type 2 diabetes in humans.

    Review

More on Mediterranean diet

Exercise

downin humans1no changein humans1

2 studies
  1. Exercise was not clearly linked with type 2 diabetes in participants with obesity.

    Humansin participants with obesity

  2. Exercise protects against type 2 diabetes in humans.

    Review

More on Exercise

Cholecystectomy

no changein humans1OR 0.98

1 study
  1. Cholecystectomy was not clearly linked with type 2 diabetes in humans (Compared with unoperated gallstones) (OR = 0.98).

    HumansCompared with unoperated gallstones

More on Cholecystectomy

Single anastomosis sleeve ileal bypass

downin humans1−78% remission

1 study
  1. Single anastomosis sleeve ileal bypass is linked with lower type 2 diabetes in humans (Primary metabolic and bariatric surgery) (78.3% remission).

    HumansPrimary metabolic and bariatric surgery

More on Single anastomosis sleeve ileal bypass

Digital twin

downin humans1

1 study
  1. Digital twin decreases type 2 diabetes in humans.

    Review

More on Digital twin

Bariatric-metabolic surgery combined with continuity of care

downin humans1−80% remission

1 study
  1. Bariatric-metabolic surgery combined with continuity of care is linked with lower type 2 diabetes in humans (patients with obesity and type 2 diabetes mellitus) (80.00% remission).

    Humanspatients with obesity and type 2 diabetes mellitus12 months

More on Bariatric-metabolic surgery combined with continuity of care

Chromium

no changein humans1

1 study
  1. Chromium was not clearly linked with type 2 diabetes in humans (FTO rs9939609 AA/AT genotypes).

    HumansFTO rs9939609 AA/AT genotypesdietary intakefemales

More on Chromium

Intestinal bipartition

downin humans1

1 study
  1. Intestinal bipartition is linked with lower type 2 diabetes in humans (34.2% remission; 50% improved).

    Humans12 months

More on Intestinal bipartition

Sugar and salt tax

downin silico1

1 study
  1. Sugar and salt tax decreases type 2 diabetes in silico (UK representative synthetic population).

    In silicoUK representative synthetic populationLifetime simulation

More on Sugar and salt tax

Postbiotics

downin reviews1

1 study
  1. Postbiotics protect against type 2 diabetes.

    Review

More on Postbiotics

All 26

Effects

49

Mortality

upin humans4no changein humans1RR 1.21

5 studies
  1. Type 2 diabetes is linked with higher mortality in humans (coexisting T2DM and CA) (APC 2.72 then 9.55).

    Humanscoexisting T2DM and CA1999-2020

  2. Type 2 diabetes is linked with higher mortality in humans (comorbid T2DM and CHF) (4.33 in 1999 to 8.98 in 2020, APC: 7.31 after 2014).

    Humanscomorbid T2DM and CHF1999 to 2020n = 292,452

  3. Type 2 diabetes is linked with higher mortality in humans (from 1990 to 2023) (AAPC 4.8% (95% CI, 4.5-5.0) in the USA).

    Humansfrom 1990 to 2023

  4. Type 2 diabetes is linked with higher mortality in hypertensive patients (21.2% vs. 18.7%, RR 1.21, 95% CI 1.10-1.32).

    Humansin hypertensive patients

  5. Type 2 diabetes was not clearly linked with mortality in humans (confirmed undiagnosed diabetes) (HR 1.50, 95% CI 0.96-2.33, p = 0.07).

    Humansconfirmed undiagnosed diabetesover 10 yearsn = 6,712

Grip strength

downin humans2

2 studies
  1. Type 2 diabetes is linked with lower grip strength in humans (Type 2 Diabetes Mellitus) (p < 0.05).

    HumansType 2 Diabetes Mellitusn = 100

  2. Type 2 diabetes is linked with lower grip strength in individuals with T2DM vs without T2DM.

    Humansin individuals with T2DM vs without T2DMn = 237

Disability-adjusted life years

upin humans2+38% increase

2 studies
  1. Type 2 diabetes is linked with higher disability-adjusted life years in humans (T2D) (37.5% increase).

    HumansT2D1990 to 2023

  2. Type 2 diabetes is linked with higher disability-adjusted life years in humans (from 1990 to 2023).

    Humansfrom 1990 to 20231990 to 2023

Cognitive function

downin humans2

2 studies
  1. Type 2 diabetes is linked with worse cognitive function in humans (older adults).

    Humansolder adultsn = 102

  2. Type 2 diabetes is linked with worse cognitive function in humans (older adults with T2D and obesity vs controls) (g = 0.80-1.42).

    Humansolder adults with T2D and obesity vs controls

Vertebral body failure load

downin rats1

1 study
  1. Type 2 diabetes decreases vertebral body failure load in rats (diabetic ZDF rats compared with age-matched controls) (35% lower than age-matched control rats).

    Animalsdiabetic ZDF rats compared with age-matched controlsvertebral bodymales

Intra-cortical canals

downin rats1

1 study
  1. Type 2 diabetes decreases intra-cortical canals in rats (diabetic ZDF rats compared with controls).

    Animalsdiabetic ZDF rats compared with controlscentral cortical bonemales

Bone mineral density heterogeneity

upin rats1

1 study
  1. Type 2 diabetes increases bone mineral density heterogeneity in rats (late-stage diabetes in ZDF rats).

    Animalslate-stage diabetes in ZDF ratscortical and trabecular bonemales

More on Bone mineral density heterogeneity

Vertebral growth and microarchitecture

downin rats1

1 study
  1. Type 2 diabetes impairs vertebral growth and microarchitecture in rats (late-stage diabetes in ZDF rats).

    Animalslate-stage diabetes in ZDF ratsvertebral bonemales

Epicardial adipose tissue volume

upin humans1

1 study
  1. Type 2 diabetes is linked with higher epicardial adipose tissue volume in humans.

    Humansepicardial adipose tissuen = 480

More on Epicardial adipose tissue volume

Coronary atherosclerosis severity

upin humans1

1 study
  1. Type 2 diabetes is linked with higher coronary atherosclerosis severity in humans.

    Humansn = 480

All 49

Upstream

23

Body mass index

mediatesin humans4

4 studies
  1. Body mass index is linked with type 2 diabetes in humans (Mediation of the association between premature menopause and type 2 diabetes) (27.9% mediated, 95% CI 19.0%-45.8%).

    HumansMediation of the association between premature menopause and type 2 diabetesfemalesn = 136,759

  2. Body mass index is linked with type 2 diabetes in humans (association between PeLS and T2D) (89%, 95% CI 57%–100%).

    Humansassociation between PeLS and T2D

  3. Body mass index is linked with type 2 diabetes in humans (between UPF consumption and type 2 diabetes) (18%).

    Humansbetween UPF consumption and type 2 diabetes11.6 years

  4. Body mass index is linked with type 2 diabetes in humans (fast eating association with diabetes risk) (proportion mediated 0.73, 95% CI 0.65 to 0.85).

    Humansfast eating association with diabetes riskn = 155,963

More on Body mass index

HbA1c

mediatesin humans2

2 studies
  1. HbA1c is linked with type 2 diabetes in humans (35.9%).

    Humansserum

  2. HbA1c is linked with type 2 diabetes in humans (conservative outcome definition) (13.7-27.5%).

    Humansconservative outcome definition

More on HbA1c

Adiponectin

mediatesin humans1no changein humans1

1 study
  1. Adiponectin is linked with type 2 diabetes in humans (potential mediation of the relationship between visceral fat and type 2 diabetes).

    Humanspotential mediation of the relationship between visceral fat and type 2 diabetesfemales

    Genetic study finds no clear hormone effect on type 2 diabetes

    Canadian journal of diabetes
  2. Adiponectin was not clearly linked with type 2 diabetes in humans (Mendelian randomization accounting for adiposity-related traits).

    HumansMendelian randomization accounting for adiposity-related traits

    Genetic study finds no clear hormone effect on type 2 diabetes

    Canadian journal of diabetes

More on Adiponectin

Biological-age acceleration

mediatesin humans1

1 study
  1. Biological-age acceleration is linked with type 2 diabetes in humans (Approximately 33%–44% of the observed association statistically accounted for).

    HumansExploratory statistical mediation of the association between EAT-Lancet diet adherence and incident type 2 diabetesn = 155,413

    EAT-Lancet diet linked to lower type 2 diabetes risk

    Frontiers in nutrition

More on Biological-age acceleration

Exhaled carbon monoxide

mediatesin humans1

1 study
  1. Exhaled carbon monoxide is linked with type 2 diabetes in humans (mediation of the PMA–type 2 diabetes association) (5.97% mediated).

    Humansmediation of the PMA–type 2 diabetes association

More on Exhaled carbon monoxide

Surveillance period (2009-2021)

downin humans1

1 study
  1. surveillance period (2009-2021) is linked with lower type 2 diabetes in humans (age- and sex-standardised) (from 23.3% in 2009 to 19.9% in 2021).

    Humansage- and sex-standardised1987 to 2021

    Type 2 diabetes prevalence fell in Mauritius after 2009

    The lancet. Diabetes & endocrinology

APOE

no changein humans1OR 1.13

1 study
  1. APOE showed no clear effect on type 2 diabetes in humans (APOE E4/E4 versus other genotypes; recessive genetic model) (OR 1.13, 95% CI 0.73–1.75).

    ReviewAPOE E4/E4 versus other genotypes; recessive genetic model

More on APOE

Thyroid peroxidase antibodies

no changein humans1

1 study
  1. Thyroid peroxidase antibodies were not clearly linked with type 2 diabetes in humans (TPOAb positivity).

    HumansTPOAb positivityn = 4,910

More on Thyroid peroxidase antibodies

PhenoAge

mediatesin humans1

1 study
  1. PhenoAge is linked with type 2 diabetes in humans (association between metal exposure and T2DM risk) (10.9%–22.2%).

    Humansassociation between metal exposure and T2DM risk

More on PhenoAge

MT-ATP6-Pos2 methylation

mediatesin humans1

1 study
  1. MT-ATP6-Pos2 methylation is linked with type 2 diabetes in humans (mediation of PFUnDA-T2DM association) (73.7%).

    Humansmediation of PFUnDA-T2DM association

More on MT-ATP6-Pos2 methylation

All 23

Associations

525

Hypertension

upin humans9OR 3.042

9 studies
  1. Hypertension is associated with type 2 diabetes in humans (aOR = 1.77; 95% CI: 1.50-2.09).

    Humansn = 37,157

  2. Hypertension is associated with type 2 diabetes in humans (Multivariate analysis) (OR=3.042).

    HumansMultivariate analysisn = 2,097

  3. Hypertension is associated with type 2 diabetes in humans (People living with HIV receiving HAART) (AOR 6.2, 95% CI 2.5–23.1).

    HumansPeople living with HIV receiving HAARTn = 159

  4. Hypertension is associated with type 2 diabetes in postmenopausal prediabetic women (HR 3.91).

    Humansin postmenopausal prediabetic womenfemales

  5. Type 2 diabetes is associated with hypertension in humans (outpatients with versus without diabetes) (81.88% vs. 69.50%).

    Humansoutpatients with versus without diabetes

  6. Hypertension is linked with a higher risk of type 2 diabetes in age- and sex-matched controls (RR 4.55, 95% CI 4.21-4.90).

    Humansin age- and sex-matched controls2 years

  7. Hypertension is associated with type 2 diabetes in humans (Free of diabetes at baseline; multivariable-adjusted matched cohort) (HR 1.30, p < 0.001).

    HumansFree of diabetes at baseline; multivariable-adjusted matched cohortn = 76,439

  8. Hypertension is associated with type 2 diabetes in PLWH receiving ART (about twice as frequent).

    Humansin PLWH receiving ART

  9. Type 2 diabetes is linked with a higher risk of hypertension in PLWH receiving ART (about twice as high).

    Humansin PLWH receiving ART

  10. Hypertension is associated with type 2 diabetes in humans (Adjusted association among Primary Health Care users) (Adjusted prevalence ratio 3.72).

    HumansAdjusted association among Primary Health Care usersn = 3,309

More on Hypertension

Obesity

upin humans8upin reviews1HR 2.52–6

9 studies
  1. Obesity is associated with type 2 diabetes in humans (Class III obesity) (4.32-fold hazard).

    HumansClass III obesity

  2. Obesity predicts type 2 diabetes in humans (HR 2.52, 95% CI 2.06–3.09; obesity preceded diabetes in 83.87% of sequential onsets).

    HumansFive yearsn = 8,383

  3. Obesity is associated with type 2 diabetes in humans (aOR = 1.65; 95% CI: 1.35-2.01).

    Humansn = 37,157

  4. Obesity is associated with type 2 diabetes in humans (Multivariate analysis) (OR=1.588).

    HumansMultivariate analysisn = 2,097

  5. Obesity is linked with a higher risk of type 2 diabetes in humans (general adiposity strategy) (pooled HR 6.00, 95% CI 3.71-9.70).

    Humansgeneral adiposity strategyapproximately 8 years

  6. Obesity is linked with a higher risk of type 2 diabetes in humans (unadjusted, compared with normal weight) (HR 5.06, 95% CI 3.86-6.62).

    Humansunadjusted, compared with normal weight

  7. Obesity is linked with a higher risk of type 2 diabetes in humans (nonobese BMI with clinical obesity under new Lancet Commission criteria) (HR 3.18 (95% CI 3.04, 3.33)).

    Humansnonobese BMI with clinical obesity under new Lancet Commission criterian = 173,698

  8. Obesity is associated with type 2 diabetes in humans.

    Humans

  9. Obesity raises the risk of type 2 diabetes.

    Review

More on Obesity

Gestational diabetes mellitus

upin humans8+11% cumulative incidenceHR 5.87

8 studies
  1. Gestational diabetes mellitus is linked with a higher risk of type 2 diabetes in humans (sevenfold higher rate).

    Humansmedian 4.1-4.3 yearsfemalesn = 1,411,883

  2. Gestational diabetes mellitus is linked with a higher risk of type 2 diabetes in humans (versus normal glucose tolerance) (adjusted hazard 4.56-fold, 48.8% vs 11.5%).

    Humansversus normal glucose tolerance

  3. Gestational diabetes mellitus is linked with a higher risk of type 2 diabetes in humans (compared with non-GDM history) (HR 5.87, 95% CI 5.67-6.08).

    Humanscompared with non-GDM historyfemales

  4. Gestational diabetes mellitus is linked with a higher risk of type 2 diabetes in humans (AHR 10.02, 95% CI 9.53-10.52).

    Humansfemalesn = 1,153,998

  5. Gestational diabetes mellitus is associated with type 2 diabetes in humans (K-means clustering using predefined T2D subtype cluster centers).

    HumansK-means clustering using predefined T2D subtype cluster centersfemales

  6. Gestational diabetes mellitus is associated with type 2 diabetes in humans (postpartum follow-up) (11.0% cumulative incidence).

    Humanspostpartum follow-up10 yearsfemalesn = 27,173

  7. Gestational diabetes mellitus raises the risk of type 2 diabetes in humans.

    Review

  8. Gestational diabetes mellitus is associated with type 2 diabetes in humans (Mothers with a history of gestational diabetes mellitus) (6-to-10-fold increased risk).

    ReviewMothers with a history of gestational diabetes mellitusfemales

More on Gestational diabetes mellitus

Body mass index

upin humans7OR 1.18

7 studies
  1. Body mass index is associated with type 2 diabetes in humans (OR 1.18, 95% CrI 1.17–1.19 per 1 kg/m2 higher BMI).

    Humansper 1 kg/m2 higher BMImalesn = 148,363

  2. Body mass index predicts type 2 diabetes in prediabetic women.

    Humansin prediabetic womenfemales

  3. Body mass index is linked with a higher risk of type 2 diabetes in humans (Japanese employees).

    HumansJapanese employees

  4. Body mass index predicts type 2 diabetes in humans (median AUC 0.660).

    Humansn = 145,571

  5. Body mass index is linked with a higher risk of type 2 diabetes in humans.

    Humans

  6. Body mass index predicts type 2 diabetes in humans (AUC 0.66 (95% CI 0.65–0.67)).

    Humansn = 17,945

  7. Body mass index is associated with type 2 diabetes in humans (AUC = 0.66).

    Humansn = 8,841

More on Body mass index

Dementia

upin humans7HR 2.46–3.79

7 studies
  1. Type 2 diabetes is associated with dementia in humans Following type 2 diabetes diagnosis; compared with individuals without diabetes (1-year cumulative incidence: 0.55% versus 0.40%; 5-year: 2.20% versus 2.05%).

    HumansFollowing type 2 diabetes diagnosis; compared with individuals without diabetes1 and 5 years

    Type 2 diabetes linked to higher early dementia risk

    ESC Congress 2026 abstract
  2. Type 2 diabetes is associated with dementia in humans (HR 2.46, 95% CI 1.37–4.42).

    HumansType 2 diabetes with high systolic blood pressure variability versus normoglycemia with low blood pressure variability; nominal associationMedian follow-up 5.1 yearsn = 57,611

    Blood pressure swings linked to death and stroke risk

    medRxivPreprint
  3. Type 2 diabetes is linked with a higher risk of dementia in humans (linked diagnosis records definition) (HR 3.79, 95% CI 3.52-4.09).

    Humanslinked diagnosis records definition

  4. Type 2 diabetes is linked with a higher risk of dementia in humans (unfavorable/medium SDOH group) (HR 2.9 (95% CI: 1.8-4.6)).

    Humansunfavorable/medium SDOH group14 years

  5. Type 2 diabetes is associated with dementia in humans.

    Review

  6. Type 2 diabetes raises the risk of dementia in humans.

    Review

  7. Type 2 diabetes raises the risk of dementia in humans (compared to individuals without diabetes) (60-70% higher risk).

    Reviewcompared to individuals without diabetes

More on Dementia

Mortality

upin humans7HR 2.8

7 studies
  1. Type 2 diabetes is associated with mortality in humans (Compared with individuals without type 2 diabetes).

    HumansCompared with individuals without type 2 diabetes

    Type 2 diabetes linked to higher early dementia risk

    ESC Congress 2026 abstract
  2. Type 2 diabetes is associated with mortality in humans (HR 2.80, 95% CI 2.12–3.69).

    HumansType 2 diabetes with high systolic blood pressure variability versus normoglycemia with low blood pressure variabilityMedian follow-up 5.1 yearsn = 57,611

    Blood pressure swings linked to death and stroke risk

    medRxivPreprint
  3. Type 2 diabetes is linked with a higher risk of mortality in hemodialysis patients (1.76 times higher).

    Humansin hemodialysis patients

  4. Type 2 diabetes predicts mortality in humans (acutely hospitalized with acute functional decline) (adjusted OR 7.460, 95% CI 2.040-27.250).

    Humansacutely hospitalized with acute functional decline3-6 monthsn = 119

  5. Type 2 diabetes is associated with mortality in humans (coexisting with malignant neoplasms) (AAMR rose from 6.37 to 17.2 per 100,000 (APC +3.84%)).

    Humanscoexisting with malignant neoplasms1999-2024n = 357,910

  6. Type 2 diabetes is linked with a higher risk of mortality in humans (newly recorded type 2 diabetes) (RHR 1.16, 95% CI: 1.11-1.20).

    Humansnewly recorded type 2 diabetes10 years

  7. Type 2 diabetes is associated with mortality in humans (comorbid with Parkinson's disease or Alzheimer's disease) (over 20% by 2030).

    Humanscomorbid with Parkinson's disease or Alzheimer's disease

Alzheimer's disease

upin humans6HR 1.45–2.17

6 studies
  1. Type 2 diabetes is associated with Alzheimer's disease in humans.

    HumansGenetic liability to type 2 diabetes; Mendelian randomization with inconsistent sensitivity-analysis supportmales

  2. Type 2 diabetes is associated with Alzheimer's disease in humans (aRR 1.53, 95% CI 1.38–1.70).

    Review

  3. Type 2 diabetes raises the risk of Alzheimer's disease in humans.

    Review

  4. Type 2 diabetes raises the risk of Alzheimer's disease in humans.

    Review

  5. Type 2 diabetes raises the risk of Alzheimer's disease in humans (HR: 1.45-2.17, 95% CI).

    Review

  6. Type 2 diabetes raises the risk of Alzheimer's disease in humans.

    Review

More on Alzheimer's disease

Sarcopenia

upin humans5OR 1.35–1.61

5 studies
  1. Type 2 diabetes is linked with a higher risk of sarcopenia in humans (OR=1.35, P=0.029, 32.03% vs 13.76%).

    Humansn = 237

  2. Type 2 diabetes is associated with sarcopenia in humans (Compared with non-diabetic adults) (OR 1.61, 95% CI 1.26–2.06).

    ReviewCompared with non-diabetic adults

  3. Type 2 diabetes raises the risk of sarcopenia in humans.

    Review

  4. Sarcopenia raises the risk of type 2 diabetes in humans.

    Review

  5. Type 2 diabetes is associated with sarcopenia in humans.

    Reviewskeletal muscle

  6. Type 2 diabetes raises the risk of sarcopenia in humans.

    Review

  7. Sarcopenia raises the risk of type 2 diabetes in humans.

    Review

More on Sarcopenia

Polygenic risk score

upin humans4mixedin humans1OR 1.61

5 studies
  1. Polygenic risk score predicts type 2 diabetes in humans (cross-ancestry meta-analysis) (AUC = 0.788).

    Humanscross-ancestry meta-analysis

    East Asian GWAS reveals shared and distinct diabetes pathways

    Communications biology
  2. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (EPIC-Potsdam cohort).

    HumansEPIC-Potsdam cohort

  3. Polygenic risk score predicts type 2 diabetes in humans (Low-risk prediabetes cluster).

    HumansLow-risk prediabetes cluster

  4. Polygenic risk score is linked with a higher risk of type 2 diabetes in humans (African Americans, highest vs lowest tertile) (OR = 1.61; 95% CI:1.22-2.12).

    HumansAfrican Americans, highest vs lowest tertilen = 1,205

  5. Polygenic risk score predicts type 2 diabetes in humans (for diabetes onset and complications).

    Reviewfor diabetes onset and complications

More on Polygenic risk score

Triglyceride-glucose index

upin humans3mixedin humans1OR 2.2

4 studies
  1. Triglyceride-glucose index is associated with type 2 diabetes in humans (Nonlinear association; inflection point at TyG = 9.14).

    HumansCross-sectional nonlinear association; inflection point at triglyceride-glucose index = 9.14n = 1,117

  2. Triglyceride-glucose index predicts type 2 diabetes in humans (AUC 0.716).

    Humansn = 4,089

  3. Triglyceride-glucose index is linked with a higher risk of type 2 diabetes in humans (OR 2.200, 95% CI 1.925–2.518).

    Humansn = 4,089

  4. Triglyceride-glucose index is linked with a higher risk of type 2 diabetes in people living with HIV-1 infection (aOR 2.86, 95% CI 1.35-6.12).

    Humansin people living with HIV-1 infectionmedian follow-up of 14.2 yearsn = 477

  5. Triglyceride-glucose index predicts type 2 diabetes in humans (identifying T2DM (group E vs. groups A-D)) (AUC=0.90).

    Humansidentifying T2DM (group E vs. groups A-D)

More on Triglyceride-glucose index

Vitamin D

downin humans4

4 studies
  1. Vitamin D lowers the risk of type 2 diabetes in humans.

    Human trial

  2. Vitamin D lowers the risk of type 2 diabetes in humans.

    Reviewselected adults with prediabetes; supplementation sufficient to achieve 25-hydroxyvitamin D ≥40 ng/ml

  3. Vitamin D lowers the risk of type 2 diabetes in humans (Vitamin D-replete populations with prediabetes).

    ReviewVitamin D-replete populations with prediabetes

  4. Vitamin D lowers the risk of type 2 diabetes in prediabetes with vitamin D deficiency or high metabolic risk.

    Reviewin prediabetes with vitamin D deficiency or high metabolic risk

More on Vitamin D

Metformin

downin humans3−40% diabetes risk reductionRR 0.65

3 studies
  1. Metformin lowers the risk of type 2 diabetes in humans (RR = 0.65, 95% CI [0.55, 0.77]).

    Human trial

  2. Metformin lowers the risk of type 2 diabetes in humans (prediabetes) (RR 0.65, 95% CI 0.55–0.77).

    Human trialprediabetes

  3. Metformin lowers the risk of type 2 diabetes in humans (Nigerians with prediabetes) (40% diabetes risk reduction).

    Human trialNigerians with prediabetes12 weeks

    Exercise and metformin cut blood sugar in Nigerians with prediabetes

    West African journal of medicine
  4. Metformin lowers the risk of type 2 diabetes in selected high-risk individuals with prediabetes.

    Reviewin selected high-risk individuals with prediabetes

More on Metformin

Tirzepatide

downin humans3

3 studies
  1. Tirzepatide lowers the risk of type 2 diabetes in humans (stratified by glycemic high-risk criteria, compared with placebo) (90% to 99% reduction in high-risk groups; 68% to 91% in standard-risk groups).

    Human trialstratified by glycemic high-risk criteria, compared with placebo3-year

  2. Tirzepatide lowers the risk of type 2 diabetes in humans.

    Human trial176 weeksn = 1,032

  3. Tirzepatide lowers the risk of type 2 diabetes in humans (compared with semaglutide).

    Reviewcompared with semaglutide

  4. Tirzepatide lowers the risk of type 2 diabetes in the prediabetes subgroup of SURMOUNT-1.

    Reviewin the prediabetes subgroup of SURMOUNT-1through 176 weeks

More on Tirzepatide

GLP-1 receptor agonists

downin humans2upin humans1

3 studies
  1. GLP-1 receptor agonists lower the risk of type 2 diabetes in humans (ranked second in the network).

    Human trialranked second in the network

  2. GLP-1 receptor agonists are associated with type 2 diabetes in humans (adults with hypertension, NHANES 2017 to March 2020) (99% vs 18%).

    Humansadults with hypertension, NHANES 2017 to March 2020n = 4,016

  3. GLP-1 receptor agonists lower the risk of type 2 diabetes in high-risk individuals.

    Reviewin high-risk individuals

More on GLP-1 receptor agonists

GLP-1 and gip receptor agonists

downin humans2HR 0.31

2 studies
  1. GLP-1 and gip receptor agonists lower the risk of type 2 diabetes in humans (compared with control, network meta-analysis).

    Human trialcompared with control, network meta-analysis

  2. GLP-1 and gip receptor agonists are linked with a lower risk of type 2 diabetes in humans (pre-conception use versus metformin in PCOS/PMOS; exploratory analysis) (HR 0.31; 95% CI 0.30-0.33).

    Humanspre-conception use versus metformin in PCOS/PMOS; exploratory analysistwo yearsfemalesn = 48,126

More on GLP-1 and gip receptor agonists

All 525

Trial sponsors

Funding

352 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$110MNational Institute on Aging$104MNational Heart, Lung, and Blood Institute$14.9M

Latest

Nature Communications

Genetic links to height differ as children grow

Analyses of 574,580 measurements from 72,704 Norwegian children identified distinct genetic links to height during infancy, childhood and across life.Analyses of 574,580 measurements from 72,704 Norwegian children identified distinct genetic links to height during infancy, childhood and across life.

Genetic association · 72,704 peoplePopulations
Research Square

Fat density linked to disease patterns in 22,710 patients

After accounting for fat area, density remained associated with 90% of 392 health traits linked to the combined fat measures.After accounting for fat area, density remained associated with 90% of 392 health traits linked to the combined fat measures.

Preprint: cross-sectional · 22,710 peopleBiomarkers

See all 14,124 papers on type 2 diabetes